Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2005
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial
Thomas Elter, Peter Borchmann, Holger Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Improvement of overall survival in advanced stage mantle cell lymphoma
Annina Herrmann, Eva Hoster, Thomas Zwingers, et al.
European Journal of Haematology
|
July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
German Medical Science : GMS E-Journal
|
June 24, 2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis
Katrin Patrij, Marcel Reiser, Luise Wätzel, et al.
Journal of Cancer Research and Clinical Oncology
|
March 8, 2023
Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany
Andreas Schmidt, Christiane Bernhardt, Dieter Bürkle, et al.
International Journal of Cancer
|
March 24, 2026
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315)
Fabian Acker, Katharina Wenger, Martin Reck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2026
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315)
Friederike C Althoff, Horst-Dieter Hummel, Konrad Kokowski, et al.
International Journal of Cancer
|
September 9, 2025
Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE
Karin Potthoff, Jens Uhlig, Lutz Jacobasch, et al.
Blood
|
December 14, 2004
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
Martin Dreyling, Georg Lenz, Eva Hoster, et al.
Leukemia
|
March 6, 2026
Patient characteristics and treatment outcomes in marginal zone lymphoma: results of the prospective German MZL registry
Alexander Grunenberg, Birgit Schmelzle, Jacqueline Gökeler, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2005
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial
Thomas Elter, Peter Borchmann, Holger Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Improvement of overall survival in advanced stage mantle cell lymphoma
Annina Herrmann, Eva Hoster, Thomas Zwingers, et al.
European Journal of Haematology
|
July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
German Medical Science : GMS E-Journal
|
June 24, 2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis
Katrin Patrij, Marcel Reiser, Luise Wätzel, et al.
Journal of Cancer Research and Clinical Oncology
|
March 8, 2023
Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany
Andreas Schmidt, Christiane Bernhardt, Dieter Bürkle, et al.
International Journal of Cancer
|
March 24, 2026
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315)
Fabian Acker, Katharina Wenger, Martin Reck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2026
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315)
Friederike C Althoff, Horst-Dieter Hummel, Konrad Kokowski, et al.
International Journal of Cancer
|
September 9, 2025
Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE
Karin Potthoff, Jens Uhlig, Lutz Jacobasch, et al.
Blood
|
December 14, 2004
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
Martin Dreyling, Georg Lenz, Eva Hoster, et al.
Leukemia
|
March 6, 2026
Patient characteristics and treatment outcomes in marginal zone lymphoma: results of the prospective German MZL registry
Alexander Grunenberg, Birgit Schmelzle, Jacqueline Gökeler, et al.
Page
of 8